Fri, April 29, 2022
Thu, April 28, 2022
Wed, April 27, 2022
Tue, April 26, 2022

Christopher Raymond Maintained (AMGN) at Buy with Increased Target to $260 on, Apr 28th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-260-on-apr-28th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Christopher Raymond of Piper Sandler, Maintained "Amgen Inc." (AMGN) at Buy with Increased Target from $255 to $260 on, Apr 28th, 2022.

Christopher has made no other calls on AMGN in the last 4 months.



There are 5 other peers that have a rating on AMGN. Out of the 5 peers that are also analyzing AMGN, 4 agree with Christopher's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Carter Gould of "Barclays" Maintained at Hold with Increased Target to $236 on, Tuesday, April 12th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $237 on, Tuesday, April 12th, 2022
  • Mohit Bansal of "Wells Fargo" Maintained at Hold with Increased Target to $250 on, Wednesday, February 9th, 2022
  • Geoff Meacham of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $255 on, Wednesday, January 5th, 2022


This is the rating of the analyst that currently disagrees with Christopher


  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $285 on, Wednesday, February 9th, 2022

Publication Contributing Sources